Skip to main content

Antipyrine and Benzocaine Ear Drops Prescribing Information

Package insert / product label
Dosage form: otic solution
Drug class: Otic anesthetics

Medically reviewed by Drugs.com. Last updated on Mar 25, 2024.

Antipyrine and Benzocaine Ear Drops Description

Antipyrine and Benzocaine Otic Solution is an otic solution containing Antipyrine, Benzocaine, Oxyquinoline Sulfate, and Anhydrous Glycerin for use in the ear. The solution congeals at 0°C (32°F), but returns to normal consistency, unchanged, at room temperature.

Antipyrine is an analgesic with local anesthetic action, it is chemically 2,3-dimethyl-1-phenyl-3-pyrazolin-5-one. The active ingredient is represented by the structural formula:

Antipyrine structural formula

C11H12N2O
Mol. Wt. 188.22

Antipyrine occurs as colorless crystals or white powder, has a slightly bitter taste and is soluble in water and alcohol.

Benzocaine is a local anesthetic. It is chemically ethyl p-aminobenzoate or Benzoic acid, 4-amino-, ethyl ester. The active ingredient is represented by the structural formula:

Benzocaine Structural formula

C9H11NO2
Mol. Wt. 165.19

It occurs as white crystals or white crystalline powder and is slightly soluble in water and soluble in organic solvents.

Each mL Contains: ACTIVES: Antipyrine 54 mg (5.4%), Benzocaine 14 mg (1.4%); INACTIVES: Glycerin, Oxyquinoline Sulfate.

Antipyrine and Benzocaine Ear Drops - Clinical Pharmacology

Antipyrine and Benzocaine Otic Solution combines the hygroscopic property of anhydrous glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and to alleviate pain and discomfort in acute otitis media.

Antipyrine and Benzocaine Otic Solution does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.

Indications and Usage for Antipyrine and Benzocaine Ear Drops

Acute Otitis media of various etiologies

-prompt relief of pain and reduction of inflammation in the congestive and serous stages.

-adjuvant therapy during systemic antibiotic administration for resolution of the infection.

Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequent problem, especially in children in whom the tube is shorter, wider, and more horizontal than in adults.

Removal of Cerumen

-facilitates the removal of excessive or impacted cerumen.

Contraindications

The product is contraindicated in any person with hypersensitivity to any of the components or substances related to them. This product is contraindicated in the presence of spontaneous perforation of the tympanic membrane or discharge.

Warnings

FOR USE IN EARS ONLY- NOT FOR USE IN EYES

Discontinue promptly if sensitization or irritation occurs.

Precautions

Information for Patients:

Avoid contaminating the dropper with material from the ear, fingers or other source.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

No long term studies have been conducted.

Pregnancy:

Category C. Animal reproduction studies have not been conducted with Antipyrine and Benzocaine Otic Solution. It is also not known whether Antipyrine and Benzocaine Otic Solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Antipyrine and Benzocaine Otic Solution should be given to a pregnant woman only if clearly needed.

Nursing Mothers:

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Antipyrine and Benzocaine Otic Solution is administered to a nursing woman.

Antipyrine and Benzocaine Ear Drops Dosage and Administration

Acute otitis media: Instill Antipyrine and Benzocaine Otic Solution, permitting the solution to run along the wall of the ear canal until it is filled. Avoid touching the ear with dropper. Then moisten a cotton pledget with Antipyrine and Benzocaine Otic Solution and insert into meatus. Repeat every one to two hours until pain and congestion are relieved.

Removal of Cerumen:

Before: Instill Antipyrine and Benzocaine Otic Solution three times daily for two or three days to help detach cerumen from wall of ear canal and facilitate removal.

After: Antipyrine and Benzocaine Otic Solution is useful for drying out the ear canal or relieving discomfort.

Before and after removal of cerumen, a cotton pledget moistened with Antipyrine and Benzocaine Otic Solution should be inserted into the meatus following instillation.

Use of Dropper:

Remove cap from bottle and discard. Remove dropper from package. Place dropper in bottle and use as directed. After use, do not rinse dropper and place dropper in bottle and close tightly.

NOTE: Do not use if solution is brown or contains a precipitate.

DISCARD THIS PRODUCT SIX MONTHS AFTER DROPPER IS FIRST PLACED IN THE DRUG SOLUTION.

How is Antipyrine and Benzocaine Ear Drops supplied

Antipyrine and Benzocaine Otic Solution USP is supplied in an amber glass bottle with a dropper in the following size:

10 mL - Prod. No. 12409

image

Storage: Store between 15°-25°C (59°- 77°F). PROTECT FROM LIGHT AND HEAT.


KEEP OUT OF REACH OF CHILDREN.


Revised February 2008

Bausch & Lomb Incorporated
Tampa, FL 33637
©Bausch & Lomb Incorporated

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Carton Image

NDC 24208-561-62

BAUSCH & LOMB

Antipyrine and Benzocaine Otic Solution USP

Rx Only

[icon- ear]

USE IN EARS ONLY

10 mL With Dropper

ANTIPYRINE AND BENZOCAINE
antipyrine and benzocaine solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:24208-561
Route of AdministrationAURICULAR (OTIC)
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ANTIPYRINE (UNII: T3CHA1B51H) (ANTIPYRINE - UNII:T3CHA1B51H) ANTIPYRINE54 mg in 1 mL
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE14 mg in 1 mL
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)
OXYQUINOLINE SULFATE (UNII: 61VUG75Y3P)
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:24208-561-621 in 1 CARTON
110 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other09/30/199005/31/2017
Labeler - Bausch & Lomb Incorporated (196603781)
Establishment
NameAddressID/FEIBusiness Operations
Bausch & Lomb Incorporated079587625MANUFACTURE(24208-561)